tiprankstipranks
Trending News
More News >

CureVac Announces Key Resolutions from Annual Shareholders Meeting

Story Highlights
CureVac Announces Key Resolutions from Annual Shareholders Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from CureVac ( (CVAC) ).

On June 24, 2025, CureVac N.V. held its annual general meeting of shareholders, where several key resolutions were passed. The shareholders approved the adoption of the 2024 annual accounts, released managing and supervisory directors from liability for the previous financial year, and appointed new members to the management and supervisory boards. Additionally, the meeting authorized the management board to issue shares, limit pre-emption rights, and amend supervisory board compensation. These decisions reflect a strategic alignment and governance strengthening, potentially enhancing CureVac’s operational capabilities and stakeholder confidence.

The most recent analyst rating on (CVAC) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on CureVac stock, see the CVAC Stock Forecast page.

Spark’s Take on CVAC Stock

According to Spark, TipRanks’ AI Analyst, CVAC is a Outperform.

CureVac’s overall stock score reflects strong financial improvements and an attractive valuation. Technical analysis indicates bullish momentum, although the RSI suggests caution. The historical volatility in financial metrics remains a potential risk.

To see Spark’s full report on CVAC stock, click here.

More about CureVac

CureVac N.V. is a biotechnology company based in Tübingen, Germany, primarily focused on developing mRNA-based therapies and vaccines. The company operates within the pharmaceutical and biotechnology industry, with a strong emphasis on innovative treatments and preventive solutions.

Average Trading Volume: 1,179,175

Technical Sentiment Signal: Buy

Current Market Cap: $1.22B

Find detailed analytics on CVAC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1